Overview
Dementia affects millions of people, more and more every year. We are proud to be leaders in Alzheimer’s research and are committed to finding a cure for this devastating disease.
Contact Us
Therapeutic Areas of Expertise
Neuroscience
8+
Sites
8+
Specialists
400+
Trials
2,000+
Participants
Capabilities
- Neurologists, Psychiatrists, and Psychologists
- Experienced dedicated raters (ADAS-Cog, RBANS, CDR-S, CGIC, C-SSRS, Digit Span, Forward and Backward, FCSRT, MMSE, MoCA, ADL)
- Psychometrics evaluation rooms
- 1.5T and 3T MRI
- fMRI
- Open MRI
- PET/CT
- Lumbar puncture
- Dedicated infusion suites
- Overnight capabilities
Key Opinion Leaders
Cherian Verghese, MD
Cherian Verghese, MD, is a board-certified psychiatrist and an industry thought leader in Alzheimer’s disease who has dedicated his career to developing new medications to treat neuropsychiatric disorders. He served as Inpatient Director and Associate Chair of psychiatry at the Albert Einstein Medical Center in Philadelphia. In 2003, he founded Keystone Clinical Studies. He has been the Principal Investigator on over 130 clinical trials and has been instrumental in the FDA approval of medications in over 10 different indications. Dr. Verghese is also founding member of the CNS Summit.
Learn More
M. Reza Bolouri, MD
M. Reza Bolouri, MD, is a board-certified neurologist. Dr. Bolouri has over 20 years of research experience in Alzheimer’s disease.
Flourish Research News
Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.